I received no letter. Did anyone receive the lett
Post# of 148115
"Leronlimab is under investigation as a treatment for HIV, breast cancer, solid tumors, NASH, and COVID-19."
Not too shabby for an OTC company. If there is a viable plan to unlock the value in Cytodyn, any sensible investor would listen. This group only throws mud and investors wipe it off their boots. OTOH, NP needs to disclose his own plan for unlocking the value in the company. Playing footsie with the FDA is trying everyone's patience.